Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy.
Coller
B S
BS
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000097:blood*; D003327:Coronary Disease / Q000097:blood* / Q000628:therapy; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage* / Q000097:blood*; D008991:Monitoring, Physiologic; D009391:Nephelometry and Turbidimetry; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000097:blood*; D010979:Platelet Function Tests / Q000379:methods; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab